Injury to the big toe leads to an unexpected lymphoma

Share this content:
Injury to the big toe leads to an unexpected lymphoma
Injury to the big toe leads to an unexpected lymphoma


  • Primary cutaneous diffuse large B-cell lymphoma, leg type, is an extranodal lymphoma that manifests as painless red or bluish nodules on the lower extremities.
  • Prognosis is poor, especially if multiple nodules are present at diagnosis, and relapse is common.
  • Treatment consists of anthracycline-based chemotherapy with rituximab, with or without radiation.


An 80-year-old white woman with hypertension and hypothyroidism presents to the dermatologist for a persistent swollen lesion on her left big toe. Five months before her visit, she had dropped a bottle of ice water on her toe. Painless swelling and erythema developed in the toe soon after, and the swelling slowly progressed in size. Approximately 6 weeks later, she presented to an orthopedist. Radiographs were negative for fracture. She was treated with nonsteroidal anti-inflammatory drugs (NSAIDs) and oral antibiotics, but the lesion did not improve. She then visited a podiatrist, who removed the toenail (Figure 1).

A punch biopsy from the left toe lesion was obtained. The pathology showed a CD20+ dense dermal lymphoid infiltrate. Immunohistochemical stains were positive for Mum1, bcl-2, and FOXP1, consistent with primary cutaneous diffuse large B-cell lymphoma, leg type. The patient was referred to an oncologist. PET scan showed hypermetabolism in the left big toe and left second toe only (Figure 2).

The patient was treated with four cycles of rituximab, etoposide, prednisone, Oncovin, cyclophosphamide, and doxorubicin (R-EPOCH) followed by radiation therapy. She had a complete response and had no signs of recurrent disease 3 months after completing radiation therapy (Figure 3).


Page 1 of 2
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs